What is a stock summary page? Click here for an overview.
Business Description
BiomX Inc
NAICS : 325412
SIC : 2834
ISIN : US09090D1037
Description
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.76 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -0.59 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 55.1 | |||||
| 3-Year EPS without NRI Growth Rate | 41.4 | |||||
| 3-Year FCF Growth Rate | 38.3 | |||||
| 3-Year Book Growth Rate | -73.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.8 | |||||
| 9-Day RSI | 62.19 | |||||
| 14-Day RSI | 54.1 | |||||
| 3-1 Month Momentum % | -28.68 | |||||
| 6-1 Month Momentum % | -33.54 | |||||
| 12-1 Month Momentum % | -82.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.48 | |||||
| Quick Ratio | 2.48 | |||||
| Cash Ratio | 2.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -82.8 | |||||
| Shareholder Yield % | 46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -106.78 | |||||
| ROA % | -31.83 | |||||
| ROIC % | -126.5 | |||||
| 3-Year ROIIC % | -0.48 | |||||
| ROC (Joel Greenblatt) % | -127.69 | |||||
| ROCE % | -38.66 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.04 | |||||
| EV-to-EBIT | -1.48 | |||||
| EV-to-Forward-EBIT | -0.57 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-Forward-EBITDA | -0.57 | |||||
| EV-to-FCF | -0.72 | |||||
| Earnings Yield (Greenblatt) % | -67.57 | |||||
| FCF Yield % | -242.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:PHGE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BiomX Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.988 | ||
| Beta | 1.98 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.89 | ||
| Volatility % | 51.33 | ||
| 14-Day RSI | 54.1 | ||
| 14-Day ATR ($) | 0.05649 | ||
| 20-Day SMA ($) | 0.56526 | ||
| 12-1 Month Momentum % | -82.6 | ||
| 52-Week Range ($) | 0.477 - 4.99 | ||
| Shares Outstanding (Mil) | 24.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BiomX Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BiomX Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BiomX Inc Frequently Asked Questions
What is BiomX Inc(PHGE)'s stock price today?
The current price of PHGE is $0.61. The 52 week high of PHGE is $4.99 and 52 week low is $0.48.
When is next earnings date of BiomX Inc(PHGE)?
The next earnings date of BiomX Inc(PHGE) is 2025-05-21 Est..
Does BiomX Inc(PHGE) pay dividends? If so, how much?
BiomX Inc(PHGE) does not pay dividend.
Guru Commentaries on AMEX:PHGE
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers